Sie sind auf Seite 1von 2

Page 1

Cancer Immunotherapy Will Supersede Traditional Treatment Methods


Cancer Immunotherapy Market & Clinical Pipeline Insight Report Highlights:
Cancer Immunotherapy Market Overview
Cancer Immunotherapy Market Dynamics
Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline
Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country
Cancer Vaccine Clinical Pipeline by Phase & Country
Oncolytic Viruses Clinical Pipeline by Phase & Country
Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country
Cancer Cell Therapy Clinical Trial Insight by Phase & Country
Currently there are 605 Cancer Monoclonal Antibodies, 289 Cancer Vaccines, 40
Oncolytic Viruses Drugs, 64 Cytokines Therapies & 82 Cell Therapies are in Clinical
Pipeline
The traditional methods in treating cancer include radiation, chemotherapy, and surgery. All
these methods are based on destroying the cancer cells either by burning them through
radiation, poisoning them through chemotherapy or by removing them by surgery. Though
these treatment options have been successful in effectively killing or removing the cancer
cells, their use has been limited to a great extent because of the major side effect that a
large number of healthy cells are also destroyed. This generally results in high morbidity
and/or disfigurement of the patients. On some cases, these treatments could also possibly
lead to the death of the patient.
Till date, there is no single best treatment for treating cancer. Instead, it is currently
believed that only a combination of different therapies which have varied mechanisms of
action could be the best choice for controlling or destroying the cancer cells. In this regard,
immunotherapy has recently been identified as a better efficient solution to cancer therapy.
It has been observed that immunotherapies have the potential to be used as a major weapon
in fighting cancer either through an application of an external stimulus to the immune system
so as to make it more powerful, or by providing the immune system with man-made or
naturally-derived tumor specific proteins which are made outside the human body, with an
Page 2
objective that the immune system could recognize the tumor as a foreign entity and destroy
it.
It has been observed that the conventional chemotherapy and other drugs used for treating
cancer generally tend to have a powerful effect in reducing the tumors in terms of size.
However, their major disadvantage is that the effect of these methods is short-lived. Also,
there are many strong side effects which are associated with these therapies. On the
contrary, the impact of immunotherapy is likely to last much longer mainly because this
therapy successfully resets the entire immune system and also enables it to continuously fight
the cancer cells. Thus, immunotherapy for cancer has been identified as having the potential
to transform a large share of cancers into a situation similar to a chronic disease.
For Report Sample Visit: Cancer Immunotherapy Market & Clinical Pipeline Insight
Or contact: avinash@kuickresearch.com

Das könnte Ihnen auch gefallen